It is not specific medical advice for any individual. All answers to reader questions are provided for informational purposes. All information presented on our websites should not be construed as medical consultation or instruction. Readers are advised to consult a health professional about any issue regarding their health and well-being. The opinions expressed in Newsmaxhealth. Please note that this advice is generic and not specific to any individual. You should consult with your doctor before undertaking any medical or nutritional course pharacejtical action. Newsmax, Moneynews, Newsmax Health, and Independent.
Trending News
Editorial Board. The pharmaceutical industry makes money from producing and selling vaccines. Companies that make food, cars, and software have the same primary motivation. The same goes for taxi drivers and web designers. As it happens, vaccines are not the most profitable products developed by the pharmaceutical sector. Medicines for patients with chronic diseases, which are taken every day, would be more profitable than a vaccine which provides a long-lasting impact. However, spending on vaccines can bring direct savings for the public purse. Purchasing vaccines for polio, for example, can reduce the risk of having to spend heavily on medicines and rehabilitation. Some people are uneasy with the idea that companies could profit from selling vaccines but if new vaccines are to be developed, huge investments are required.
Bonus benefits: flu vaccine does more than protect against influenza
When pharmaceutical companies develop a new drug that markets well, they make money from selling said drug. All Rights Reserved. The material on this site can not be reproduced, distributed, transmitted, cached or otherwise used, except with prior written permission of Multiply. Hottest Questions. Previously Viewed. Unanswered Questions. Asked in Pharmaceutical Industry. How do pharmaceutical companies make money? Related Questions Asked in Health What are the negative effects of national health care? Pharmaceutical companies and insurance companies will not make as much money! Asked in Pharmaceutical Industry How much money did the pharmaceutical companies make last year?
Aren’t Vaccines Just Moneymakers for Pharmaceutical Companies?
Business development heads must take a long hard look at their company’s pipelines and pursue stronger vaccine portfolios. As the global demand for vaccines and their profitability continue to soar, pharmaceutical and biotech companies are increasingly looking for ways to secure the most lucrative partnerships possible to advance their vaccine platform development. It’s not a lot. That’s why the federal government made the vaccine injury court to accept the liability of vaccines. They are very beneficial but since they are only given 1 to 3 times for a lifetime of benefit the companies don’t make a lot of money. Without the vaccine injury court even the extremely uncommon injuries from vaccines would make them unprofitable. When Eli Lilly approximate yearly revenues 20 billion developed Thiomersal and was promptly almost sued out of existence for it’s wonderful contribution to modern medicine, few other companies wanted to get in the vaccine game, and we went from about 25 global vaccine producing companies to FIVE.
The History Of Vaccines And Why Sales Are Rising
Bonus benefits: flu vaccine does more than protect against influenza
Industry-specific and extensively researched technical data partially from exclusive partnerships. A paid subscription is required for full access. You need a Premium Account for unlimited access. Additional Information. Show source. Show sources information Show publisher information. Research and development in European pharmaceutical industry by country Employment in European pharmaceutical industry by country As a Premium user you get access to the detailed source references and background information about this statistic. As a Premium user you get access to background information and details about the release of this statistic. This feature is limited to our corporate solutions. Please contact us to get started with full access to dossiers, forecasts, studies and international data.
Comments
Post a Comment